These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 10594933

  • 1. Effects of mistletoe lectin I and ionizing radiation on the glucose and thymidine uptake in tumour cells in vitro.
    Kubasova T, Petcu I, Pfüller U, Köteles GJ.
    Phytother Res; 1999 Dec; 13(8):655-9. PubMed ID: 10594933
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G, Jung ML, Frantz M, Anton R.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [Abstract] [Full Text] [Related]

  • 3. Differences in the apoptosis-inducing properties of Viscum album L. extracts.
    Büssing A, Suzart K, Schweizer K.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S9-14. PubMed ID: 9179360
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N, Kalisnik T, Loncarić I, Borović S, Mang S, Kissel D, Konitzer M, Jurin M, Grainza S.
    Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
    Kunze E, Schulz H, Gabius HJ.
    J Cancer Res Clin Oncol; 1998 Apr; 124(2):73-87. PubMed ID: 9654190
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J.
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells.
    Kim MS, So HS, Lee KM, Park JS, Lee JH, Moon SK, Ryu DG, Chung SY, Jung BH, Kim YK, Moon G, Park R.
    Gen Pharmacol; 2000 May; 34(5):349-55. PubMed ID: 11368891
    [Abstract] [Full Text] [Related]

  • 12. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
    Kunze E, Schulz H, Adamek M, Gabius HJ.
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
    [Abstract] [Full Text] [Related]

  • 13. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V.
    J Biol Regul Homeost Agents; 1993 Mar; 7(1):1-6. PubMed ID: 8346712
    [Abstract] [Full Text] [Related]

  • 14. Preparation of alginate/chitosan microcapsules and enteric coated granules of mistletoe lectin.
    Lyu SY, Kwon YJ, Joo HJ, Park WB.
    Arch Pharm Res; 2004 Jan; 27(1):118-26. PubMed ID: 14969350
    [Abstract] [Full Text] [Related]

  • 15. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
    Galanina OE, Kaltner H, Khraltsova LS, Bovin NV, Gabius HJ.
    J Mol Recognit; 1997 Jan; 10(3):139-47. PubMed ID: 9408830
    [Abstract] [Full Text] [Related]

  • 16. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
    Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H, Saller R.
    Nat Immun; 1998 Jan; 16(1):34-46. PubMed ID: 9789123
    [Abstract] [Full Text] [Related]

  • 17. Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro.
    Hostanska K, Hajto T, Fischer J, Mengs U, Weber K, Lentzen H, Saller R.
    Cancer Detect Prev; 1999 Jan; 23(6):511-23. PubMed ID: 10571662
    [Abstract] [Full Text] [Related]

  • 18. Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro.
    Stettin A, Schultze JL, Stechemesser E, Berg PA.
    Klin Wochenschr; 1990 Sep 14; 68(18):896-900. PubMed ID: 2124308
    [Abstract] [Full Text] [Related]

  • 19. Mistletoe lectins and their A and B chains.
    Franz H.
    Oncology; 1986 Sep 14; 43 Suppl 1():23-34. PubMed ID: 3543782
    [Abstract] [Full Text] [Related]

  • 20. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM, Stettin A, Schultze J, Berg PA.
    Anticancer Drugs; 1997 Apr 14; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.